Medication info

Gasporin F Tablet

Prescription medicationOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tabletTripotassium Bismuth Dicitrate›200mg / 1 tabletSucralfate Hydrate›600mg / 1 tablet
Manufacturer / importer
Anguk Pharmaceutical Co., Ltd.
Appearance
Green oblong film-coated triple tablet
Packaging
30 tablets, 300 tablets
Approval status
Expired

MFDS item code 201506748 · Approved 2015.09.24

This product's status changed to Expired on 2025.09.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers and gastritis) and prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
○ Adults The usual dose is 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher rate of healing may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, the healing period may occasionally be longer in some patients. For patients with recurrent ulcers who responded particularly well to short-term treatment with this drug, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 1 tablet twice daily or 2 tablets once daily at bedtime. However, the dose may be increased to 2 tablets 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 1 tablet 3 times daily, and increase the dose as needed. For severe disease, up to 6 g per day as ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 1 tablet twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is preferable to also administer 1 tablet on the night before surgery.

Ingredients

Manufacturer
Anguk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers and gastritis) and prevention of Mendelson's syndrome

  • Gastric ulcer
  • duodenal ulcer
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • post-surgical ulcer
  • NSAID-induced gastric ulcer
  • NSAID-induced duodenal ulcer
View approved original text

This medication is used for diseases such as gastric and duodenal ulcers, gastritis, and Zollinger-Ellison syndrome. It is also effective for gastroesophageal reflux disease and may be administered to prevent Mendelson's syndrome during pre-anesthesia. It is also used to treat ulcers that may occur post-surgery or gastric and duodenal ulcers resulting from nonsteroidal anti-inflammatory drugs (NSAIDs). This drug helps to alleviate and treat symptoms of these diseases.

How to take

Adult dose

○ Adults The usual dose is 1 tablet orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Administer 1 tablet twice daily or 2 tablets once daily at bedtime. In particular, a higher rate of healing may be achieved in patients with duodenal ulcers by administering 2 tablets twice daily, in the morning and at bedtime. The same dosage applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, the healing period may occasionally be longer in some patients. For patients with recurrent ulcers who responded particularly well to short-term treatment with this drug, administer 1 tablet once daily at bedtime as maintenance therapy. 2) Reflux esophagitis For 8 weeks, administer 1 tablet twice daily or 2 tablets once daily at bedtime. However, the dose may be increased to 2 tablets 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 1 tablet 3 times daily, and increase the dose as needed. For severe disease, up to 6 g per day as ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 1 tablet twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 1 tablet 2 hours before induction of anesthesia. In this case, it is preferable to also administer 1 tablet on the night before surgery.

Precautions

This medication should not be used in patients with poor renal function or those undergoing dialysis. Additionally, it should not be given to patients who have had allergic reactions to this drug or its components, have a history of acute porphyria, have undergone upper gastrointestinal surgery, are pregnant or may become pregnant, premature infants and newborns, and patients on a potassium-restricted diet. Caution is required when using this drug in patients with poor liver function, a history of drug allergies, the elderly, those with previous renal function issues, and patients taking NSAIDs. Particularly, symptoms of gastric cancer may be hidden, so patients over middle age with gastric ulcer or new or changing dyspeptic symptoms should confirm the malignancy before treatment. Patients with Helicobacter pylori infection with gastric or duodenal ulcers require eradication therapy and caution should be exercised in critically ill patients, patients with hypophosphatemia, and those with swallowing difficulties. Rarely during treatment with this medication, allergic reactions, blood abnormalities, liver dysfunction, cardiac arrhythmias, gastrointestinal disorders, and neurological symptoms may occur, so immediate consultation with a doctor is necessary if abnormal symptoms appear. Avoid long-term use, and if there is no therapeutic effect, switch to another medication, and routinely conduct blood tests and liver/renal function tests. The elderly or patients with chronic lung disease, diabetes, and those with weakened immunity may have an increased risk of pneumonia, and if dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so if you are taking other medications, it is crucial to inform your doctor or pharmacist, and some drugs may need to be taken with an interval. Pregnant or breastfeeding women are advised against using this drug, and safety in children has not been established, so administration is not recommended. In case of overdose, appropriate treatment such as vomiting and gastric lavage should be given, and blood dialysis may be performed if necessary. Finally, this medication can reduce gastric acid secretion, which can promote bacterial growth in the gastrointestinal tract, and for long-term use, ocular examinations are advisable.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 60 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • bone marrow hypoplasia
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal bloating
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • malaise
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • muscular spasms
  • gynecomastia
  • hyperprolactinemia
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • erythema multiforme
  • alopecia
  • stomatitis
  • pruritus
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container that is well-ventilated, and it is recommended to keep it at a temperature between 1 and 30 degrees Celsius. By storing it this way, the effectiveness of the medication can be well maintained.

Appearance and packaging

Appearance

Green oblong film-coated triple tablet

Package unit

30 tablets, 300 tablets

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.